Isixhobo seRumatoid - Ukuqonda iziphumo zovavanyo

Phakathi kweeMvavanyo zokuQala eziMiselweyo xa i-Arthritis ye-Rheumatoid ixhaswa

I-rheumatoid factor yi-autoantibody (ngokuqhelekileyo i-IgM) ebophelela kummandla we-Fc we-anti-gig. I-Autoantibodies iiprotheni eziveliswa ngamajoni omzimba , kodwa kunokuba zihlasele izinto zangaphandle, zihlasela izicubu zomzimba. Ukuba ugqirha wakho ugxeka ukuba unakho i- rheumatoid arthritis , i-test rheumatoid test test will surely be among the first tests of diagnostic tests.

Iimvavanyo zokuqala (iimvavanyo) zibonisa ukuba ii-autoantibodies zidibaniswe ne-rheumatoid arthritis zaphuhliswa kuma-1940. Ekuqaleni, le mvavanyo yayiyi-agglutination apho i-serum evela kwizigulane ze-rheumatoid arthritis yaboniswa ukuba ibangele imfuyo yeegusha zegazi ezibomvu ezaziye zahluthwa ngogqirha onqamle iigciwane ze-erythrocyte. Kwakukho utshintsho olwenziweyo olwenziwe kuvavanyo lokuqala lwamagqabi, ngokukodwa ngokufaka indawo ye-sheep-coated nge-lateg for the sheep cells. Ekugqibeleni, uvavanyo lwe-ELISA (e-enzyme-linked-immunosorbent assay) lwe-rheumatoid lwenziwa, kwakunye neemvavanyo ze-nephelometry.

Kwiimvavanyo zokuhlukunyezwa, ukugquma kubonakalisa umphumo omuhle. Ukunyuselwa kwimihlaba kungenziwa kunye nesampuli yokuvavanya ukucacisa i-titer. I-titer ibonisa ukuba isampuli ingahlaziywa njani ngaphambi kokuba i-rheumatoid ingabonakali (ayifuni).

Kwiimvavanyo ze-nephelometry, isampuli yegazi ixutywe kunye neengqungquthela zokubangela ukuqubuka.

Ukukhanya kuyadluliselwa kwisampuli ukucacisa izinga lokufa.

Ukuqonda iziphumo

Ngokuqhelekileyo, uluhlu oluqhelekileyo lwe-test rheumatoid test libikwe ngokuthi:

Qaphela: ii-laboratories ezahlukileyo ziyahluka kwiindlela zokuvavanya okanye i-kit yokuhlolwa, esilandela iziphumo kunye nebala eliqhelekileyo elinikezwa ngelabhuyibrari yakho ethile.

Iziphumo zemivavanyo yesifo se-rheumatoid zingadideka kwizigulane ze-arthritis. Okokuqala kwaye okokuqala, into ebaluleke kakhulu ukuba ukwazi ukuba i-test ye-rheumatoid test iyingxenye enye yolwazi esetyenziselwa ukulungiselela ukuxilongwa. Ukuxilongwa okuqinisekileyo akukaze kusekelwe kuphela kwisiphumo sovavanyo lwe-rheumatoid. Nazi ezinye iingqinisiso ezibalulekileyo malunga novavanyo lwe-rheumatoid omele ukwazi:

Ukubaluleka kweeKliniki zeZiphumo

Isiphumo sokuhlolwa kwezinto zesifo se-rheumatoid sokuqala esingakhange siphumelele singakhange siphumelele, kodwa ukufaneleka kweklinikhi yaloo nto kuhlala kumbuzo. Ngokutsho kukaScott Zashin, MD, i-rheumatologist evela e-Dallas, eTexas (scottzashinmd.com) kunye nombhali weArthritis ngaphandle kobuhlungu - Ummangaliso we-TNF Blockers kunye nombhali-mbini wencwadi yam yesibini kwincwadi ye- Natural Arthritis Treatment , "I-Rheumatologists ayilandeli i-rheumatoid factor xa kukho ukuxilongwa kwe-rheumatoid arthritis . Oku kuthetha, kwinqanaba lam, iqondo le-rheumatoid lento lingatshintshwa ngokukodwa ngemisebenzi yesifo , kodwa oko akunjalo njengeluncedo lwezonyango njengeminye imvavanyo, njengezinga le- sedimentation ye-erythrocyte , i- C- protein (CRP) , kwaye kwezinye iimeko ezinye iimpawu ezingatholakala kwiimvavanyo zeVECTRA , ezisetyenziselwa ukuhlola umsebenzi wesifo kwi-arthritis ye-rheumatoid. "

Imithombo:

I-Kelley's Bookbook yeRheumatology. INguqulelo yesithoba. I-Autoantibodies kwi-Rheumatoid Arthritis. Isahluko 56. UFelipe Andrade et al. p. 804.

I-Primer kwi-Rheumatic Diseases. Uluhlu lweSithathu. Ipapashwe ngu-Arthritis Foundation. Isahluko 6. I-Rheumatoid Arthritis. Izinto zeRumatoid. p. 126.

I-Rheumatoid Factor (RF). MedlinePlus. Ukuhlaziywa 4/20/2013.
https://www.nlm.nih.gov/medlineplus/ency/article/003548.htm